Chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in chronic lung disease (oxygen use at 28 days in survivors) compared with no supplementation (moderate certainty).
2 findings from 1 review
Death or chronic lung disease · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A probably leads to lower death or chronic lung disease (oxygen use at 28 days) compared with no supplementation (moderate certainty).
2 findings from 1 review
Death before 36 weeks' postmenstrual age · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in death before 36 weeks' postmenstrual age compared with no supplementation (moderate certainty).
1 finding from 1 review
Neurodevelopmental impairment at 18 to 22 months · promoting growth and development in very low birth weight infants receiving human milk
Supplemental vitamin A showed no clear difference in neurodevelopmental impairment at 18 to 22 months compared with no supplementation (low certainty).
1 finding from 1 review
All‐cause infant mortality at 6 months: risk ratios based on cumulative risk (%, adjusted for clustering) ‐ term infants · mortality and morbidity in term neonates
It is very uncertain whether neonatal vitamin A supplementation changes all‐cause infant mortality at 6 months: risk ratios based on… compared with control (very low certainty).
1 finding from 1 review
Infant Mortality at 6 Months · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in all‐cause infant mortality at 6 months: risk ratios based on… compared with control (high certainty).
1 finding from 1 review
Neonatal mortality · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in all‐cause neonatal mortality: risk ratios based on cumulative risk… compared with control (high certainty).
1 finding from 1 review
Adverse events during first 48‐72 hours post supplementation ‐ bulging fontanelle · mortality and morbidity in term neonates
Neonatal vitamin A supplementation leads to higher adverse events during first 48‐72 hours post supplementation ‐… compared with control (high certainty).
1 finding from 1 review
Vomiting · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in adverse events during first 48‐72 hours post supplementation ‐… compared with control (high certainty).
1 finding from 1 review
Adverse effects: diarrhoea 48 to 72 hours · mortality and morbidity in term neonates
Neonatal vitamin A supplementation showed no clear difference in adverse events during first 48‐72 hours post supplementation ‐… compared with control (low certainty).
1 finding from 1 review
Intervention not reported
Vitamin A deficiency: retinol < 0.7 μmol/L · infants 1 to 6 months of age
The intervention showed no clear difference in vitamin A deficiency: retinol < 0.7 μmol/L (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality: longest · infants 1 to 6 months of age
The intervention showed no clear difference in all‐cause mortality: longest (moderate certainty).
1 finding from 1 review
Intervention not reported
Morbidity: diarrhoea: point prevalence · infants 1 to 6 months of age
The intervention showed no clear difference in morbidity: diarrhoea: point prevalence (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: bulging fontanelle within 48 to 72 hours · infants 1 to 6 months of age
The intervention leads to higher adverse effects: bulging fontanelle within 48 to 72 hours (high certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: vomiting 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: vomiting 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: diarrhoea 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: diarrhoea 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: fever 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: fever 48 to 72 hours (low certainty).
1 finding from 1 review